Neural Regeneration Research, 2018 · DOI: 10.4103/1673-5374.238604 · Published: October 1, 2018
Traumatic brain injury (TBI) can lead to long-term complications, including depression, which can affect various aspects of life such as work and cognitive function. The exact cause of depression after TBI is unclear, but inflammation in the brain may play a role. TBI can cause ongoing inflammation in the brain, and this inflammation might contribute to depression. Cytokines, which are inflammatory molecules, are elevated after TBI and can affect how brain cells communicate. This review discusses the evidence supporting the idea that inflammation is linked to depression after TBI, focusing on how specific inflammatory molecules like TNFα and IL-1 could disrupt brain function and lead to depression.
Anti-inflammatory therapies targeting cytokines, such as TNFα and IL-1, may offer a novel approach to treating depression following TBI.
Chronic elevation of cytokines in the blood after TBI could serve as a biomarker for identifying individuals at risk for depression and predicting treatment success.
Understanding the role of inflammation in post-TBI depression can lead to more individualized and effective treatment strategies.